FloraWorks advances research into cannabinol use for sleep
The analysis appeared in Pharmaceuticals and was funded by biotech agency FloraWorks, which discovers uncommon and novel cannabinoids for industrial and therapeutic functions. The research examined FloraWorks’ TruCBN model and is the most important double blind, randomized, placebo-controlled...